# VascVersa

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vascversa

- Industry: Biotechnology
- Headquarters: Belfast, Ireland
- Website: www.vascversa.org
- Total disclosed funding: $0.6M
- Latest round: Seed (May 3, 2022)
- Investors on record: 3

## About

Based in Belfast, Ireland, and founded in 2018 by Dr. Christina O’Neill (CEO), VascVersa Ltd provides early-stage regenerative medicine to patients. In May 2021, the firm, raised GBP 500,000 seed funding from returning investors QUBIS Limited, Halo Business Angel Network, and Co-FundNI.

The company offers cell therapy products as a new treatment for vascular regeneration. It provides ANGICYTE™ technology that can develop new cell therapies to treat diseases by regenerating tissue and this act as the forefront of medicine.

The company plans to use the May 2021 funding to support its growth and accelerate the development of its first product for diabetic foot ulcers

## Funding rounds

- Seed, May 3, 2022, $0.6M — Clarendon Fund Managers, Qubis, Halo Business Angel Network

## Investors

- Clarendon Fund Managers (https://capitalatlas.ai/funds/clarendon-fund-managers) — Seed
- Qubis (https://capitalatlas.ai/funds/qubis) — Seed
- Halo Business Angel Network — Seed